Trial intelligence / Profile preview

Rectal Misoprostol for Blood Loss in Elective Cesarean Section

NCT07188207Not yet recruiting

Sponsor
Assiut University
Start
Oct 2025
Primary completion
Oct 2026
Modality
Small Molecules
01

Overview

Randomised trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Assiut University. Primary endpoint: Intraoperative and postoperative blood loss at 24 hours. Planned start Oct 2025; status: not yet recruiting.

02

Drugs

misoprostol
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT07188207.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07188207.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call